This inventor holds 27 USPTO granted patents and 5 published patent applications and 2 EPO patents, primarily in Targeted Drug Delivery. Top assignee: Hoffmann-La Roche Inc.. Active years: 1998-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Basking Ridge, NJ (US) (1998)
- Gillette, NJ (US) (2003 - 2022)
Company Filing History:
Years Active: 1998-2022
Areas of Expertise:
Title: The Innovative Mind of Robert Alan Goodnow, Jr.
Introduction:
Robert Alan Goodnow, Jr., a prolific inventor hailing from Gillette, NJ, has made significant contributions to the field of targeted drug delivery with his arsenal of 27 patents. Goodnow's groundbreaking work reflects a steadfast commitment to pushing the boundaries of pharmaceutical science.
Latest Patents:
Goodnow's latest patents showcase his expertise in the realm of targeted drug delivery. One such invention involves chitosan polymer derivatives that bind to specific integrin dimers, paving the way for precise delivery of therapeutic compounds to target tissues and cells. Another patent focuses on integrin antagonist conjugates designed for targeted delivery to cells expressing LFA-1, opening up new possibilities in drug delivery mechanisms.
Career Highlights:
Having lent his inventive prowess to esteemed companies like Hoffmann-La Roche Inc. (referred to as Roche), Goodnow has left an indelible mark on the pharmaceutical industry. His tenure at Roche speaks volumes about his innovative spirit and collaborative approach to scientific endeavors.
Collaborations:
Throughout his career, Goodnow has collaborated with esteemed colleagues such as Paul Gillespie and Achyutharao Sidduri. This synergy of minds has undoubtedly played a crucial role in the success of his groundbreaking inventions and patents.
Conclusion:
In conclusion, Robert Alan Goodnow, Jr. stands as a beacon of innovation in the realm of targeted drug delivery. His relentless pursuit of scientific excellence, coupled with his collaborative spirit, continues to shape the landscape of pharmaceutical research. Goodnow's patents not only reflect his ingenuity but also hold the promise of transforming the way we approach drug delivery in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile